The Biostatistics and Bioinformatics Core, Core III, will facilitate translational research in prostate cancer, by providing UCLA investigators and their colleagues with state of the art biostatistical, bioinformatics, data management and clinical trials support. The core provides a centralized network of biostatistics/bioinformatics support and data management for prostate cancer researchers at UCLA and their collaborators. The overall goal of the Core is to provide statistical and data management support to basic and clinical investigators in the SPORE. This includes provision of power analyses for planning of preclinical and clinical studies and statistical analysis of all completed studies prior to publication. The Core also provides analytical services for all genomics research, including sequencing and gene expression arrays within the SPORE. In addition to these statistical services, the Core plays a central role in the management of the UCLA Prostate Cancer SPORE clinical database. The Core had designed and manages the web-based Prostate SPORE clinical database. Continual improvements to the database have been made to facilitate data input and workflow, as well as to provide a seamless environment for statistical and other inquiries. The database is linked to the biospecimen repository, as well as to the tissue arrays managed by the Pathology Core. The Core aims to provide comprehensive statistical consultation and analysis to the individual projects to SPORE investigators. This will also include education in the use of statistical software, preparation of manuscripts, and development and submission of new grant applications.
It aims to provide a facility and computational leadership to design and carry out projects using high-dimensional technologies including tissue array, microarray gene expression, flow cytometry. Software and up-to-date statistical methodology will also be provided.
It aims to maintain and develop a central data repository and provide data management/quality control activities for all SPORE projects and cores. This function will include development and application of additional data management and statistical programming tools.

Public Health Relevance

An important reason for having a core dedicated for statistical support is the complexity of the statistical issues involved in the proposed SPORE research. When standard statistical methodology does not apply, new statistical and bioinformatics methods must be explored. Effective data management and reporting are a crucial precursor to high quality and reproducible statistical analyses and for sharing data with the research community

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA092131-12
Application #
8760364
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
12
Fiscal Year
2014
Total Cost
$176,382
Indirect Cost
$75,313
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lee, Ha Neul; Mitra, Mithun; Bosompra, Oye et al. (2018) RECK isoforms have opposing effects on cell migration. Mol Biol Cell 29:1825-1838
Aggarwal, Rahul; Huang, Jiaoti; Alumkal, Joshi J et al. (2018) Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol 36:2492-2503
Cheng, Larry C; Li, Zhen; Graeber, Thomas G et al. (2018) Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer. J Vis Exp :
Park, Jung Wook; Lee, John K; Sheu, Katherine M et al. (2018) Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science 362:91-95
Tan, Nelly; Shen, Luyao; Khoshnoodi, Pooria et al. (2018) Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. J Urol 199:1218-1223
Donin, Nicholas M; Reiter, Robert E (2018) Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer. J Nucl Med 59:177-182
Nagarajan, Mahesh B; Raman, Steven S; Lo, Pechin et al. (2018) Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate. Abdom Radiol (NY) 43:2487-2496
Calais, Jeremie; Fendler, Wolfgang P; Eiber, Matthias et al. (2018) Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. J Nucl Med 59:434-441
Vidal, Adriana C; Howard, Lauren E; de Hoedt, Amanda et al. (2018) Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database. Cancer Causes Control 29:581-588
Vidal, Adriana C; Howard, Lauren E; de Hoedt, Amanda et al. (2018) Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int 122:76-82

Showing the most recent 10 out of 339 publications